Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The complications of jejunostomy tubes for patients receiving Duodopa: New challenges for neuroscience nurses

The complications of jejunostomy tubes for patients receiving Duodopa: New challenges for... AbstractThe use of Duodopa ® Levodopa-Carbidopa intestinal gel offers patients with advanced Parkinson’s disease (PD) an effective alternative therapy for the treatment of severe motor fluctuations and dyskinesia. This therapy requires the use of percutaneous endoscopic gastrostomy/jejunostomy tube (PEG/J) to deliver gel directly into the jejunum which poses new challenges for neuroscience nurses for the care and management of patients with PD. Due to the reported number of complications associated with PEG/J our facility opted to use a direct jejunostomy tube for the first of two PD patients which resulted in an adverse outcome for our 80 year old patient. This experience highlighted that the neuroscience nurses need to increase knowledge and understanding of PEG/J and jejunostomy care as more future patients will be treated with Duodopa, and that future studies regarding the safety and value of the direct jejunostomy tubes are warranted. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Australasian Journal of Neuroscience de Gruyter

The complications of jejunostomy tubes for patients receiving Duodopa: New challenges for neuroscience nurses

Loading next page...
 
/lp/de-gruyter/the-complications-of-jejunostomy-tubes-for-patients-receiving-duodopa-ChPMNBKH7m

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
de Gruyter
Copyright
© 2017 Rachael Elizabeth Mackinnon., published by Sciendo
eISSN
2208-6781
DOI
10.21307/ajon-2017-001
Publisher site
See Article on Publisher Site

Abstract

AbstractThe use of Duodopa ® Levodopa-Carbidopa intestinal gel offers patients with advanced Parkinson’s disease (PD) an effective alternative therapy for the treatment of severe motor fluctuations and dyskinesia. This therapy requires the use of percutaneous endoscopic gastrostomy/jejunostomy tube (PEG/J) to deliver gel directly into the jejunum which poses new challenges for neuroscience nurses for the care and management of patients with PD. Due to the reported number of complications associated with PEG/J our facility opted to use a direct jejunostomy tube for the first of two PD patients which resulted in an adverse outcome for our 80 year old patient. This experience highlighted that the neuroscience nurses need to increase knowledge and understanding of PEG/J and jejunostomy care as more future patients will be treated with Duodopa, and that future studies regarding the safety and value of the direct jejunostomy tubes are warranted.

Journal

Australasian Journal of Neurosciencede Gruyter

Published: Nov 1, 2017

Keywords: Parkinson’s disease; percutaneous endoscopic gastrostomy/jejunostomy (PEG/J); Direct Endoscopic Jejunostomy (DEJ); Jejunostomy; Duodopa; complications

There are no references for this article.